Michael Burgess actually said...
I think we both have to agree that the timeline is a strong economic disincentive.
Context
Burgess highlights FDA approval timelines as a barrier to innovation.
04/12/2011
Burgess highlights FDA approval timelines as a barrier to innovation.
04/12/2011